Sangivamycin is highly effective against SARS-CoV-2 in vitro and has favorable drug properties.
Bennett RP, Postnikova EN, Eaton BP, Cai Y, Yu S, Smith CO, Liang J, Zhou H, Kocher GA, Murphy MJ, Smith HC, Kuhn JH.
Bennett RP, et al. Among authors: smith co.
JCI Insight. 2022 Jan 11;7(1):e153165. doi: 10.1172/jci.insight.153165.
JCI Insight. 2022.
PMID: 34807849
Free PMC article.